NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

肽合成的市場規模:產品,技術,用途,終端用戶,各地區 - 佔有率,展望,機會分析(2020年∼2027年)

Peptide Synthesis Market, by Product, by Technology, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 980020
出版日期 內容資訊 英文 200 Pages
商品交期: 2-3個工作天內
價格
肽合成的市場規模:產品,技術,用途,終端用戶,各地區 - 佔有率,展望,機會分析(2020年∼2027年) Peptide Synthesis Market, by Product, by Technology, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月24日內容資訊: 英文 200 Pages
簡介

推動全球肽合成市場增長的因素包括諸如糖尿病等代謝紊亂的發生率增加。2019年全球糖尿病患者人數估計為4.36億,預計到2030年將達到5.78億,到2045年將達到7億。但是,合成肽生產的可持續性有望阻礙市場增長。可持續和有效催化方法的發展被認為是肽合成中的主要挑戰。

本報告提供全球肽合成市場的相關調查,提供市場規模和佔有率,市場機會和趨勢,成長及阻礙因素,產品·技術·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的·前提條件

第2章 市場展望

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各產品
    • 市場明細:各技術
    • 市場明細:各用途
    • 市場明細:各終端用戶
    • 市場明細:各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 開發平台分析
  • 償付方案
  • 流行病學
  • PEST分析
  • 法規方案
  • 新產品的銷售
  • 合作與契約
  • 市場趨勢

第4章 COVID-19疫情的影響

  • COVID-19市場方案
  • COVID-19市場對肽合成產品帶來的影響

第5章 市場分析:各產品(2016-2027)

  • 簡介
  • 試劑與消耗品
  • 設備

第6章 市場分析:各技術(2016-2027)

  • 簡介
  • 固相
  • 液相
  • 混合與重組

第7章 市場分析:各用途(2016-2027)

  • 簡介
  • 治療
  • 診斷
  • 研究

第8章 市場分析:各終端用戶(2016-2027)

  • 簡介
  • 製藥·生物科技企業
  • 受託開發製造機構(CDMO)/受託調查機構(CRO)
  • 學術·研究機關

第9章 市場分析:各地區(2016-2027)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第10章 競爭情形

  • 熱圖分析
  • 市場佔有率分析
    • GenScript Biotech Corporation.
    • Merck KGaA
    • ThermoFisher Scientific Inc.
    • Syngene
    • Lonza
    • Novo Nordisk A/S
    • Bachem Holding AG
    • Gyros Protein Technologies
    • Creative Diagnostics
    • CEM Corporation
    • PuroSynth
    • AAPPTec
    • Biotage AB
    • Analyst Views

第11章 章節

目錄

Title:
Peptide Synthesis Market, by Product (Reagents & Consumables and Equipment (Peptide Synthesizers, Lyophilizers, and Chromatography Equipment)), by Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), by Application (Therapeutics (Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, and Others), Diagnosis, and Research), by End User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), and Academic & Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Peptide synthesis is characterized as the formation of a peptide bond between two amino acids. Peptide synthesis most often occurs by coupling the carboxyl group of the incoming amino acid to the N-terminus of the growing peptide chain. Peptide synthesis is a common approach in even high-throughput biological research and product and drug development.

Market Dynamics

Rising incidence of metabolic disorders such as diabetes is expected to drive the peptide synthesis market growth. For instance, according to an article published by the journal Diabetes Research and Clinical Practice - 'Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition in September 2019, 463 million people were estimated to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

However, sustainability in synthetic peptide production is expected to hinder the market growth. For instance, according to an article published by the ProteoGenix in November 2019, reports that development of sustainable and efficient catalytic methods is the major challenge in peptide synthesis.

Key features of the study:

  • This report provides in-depth analysis of the global peptide synthesis market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global peptide synthesis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global peptide synthesis market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide synthesis market.

Detailed Segmentation:

  • Global Peptide Synthesis Market, By Product:
    • Reagents & Consumables
    • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
  • Global Peptide Synthesis Market, By Technology:
    • Solid Phase
    • Liquid Phase
    • Hybrid & Recombinant
  • Global Peptide Synthesis Market, By Application:
    • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
    • Diagnosis
    • Research
  • Global Peptide Synthesis Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
    • Academic and Research Institutes
  • Global Peptide Synthesis Market, By Region:
    • North America
      • By Product:
      • Reagents & Consumables
      • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
      • By Technology:
      • Solid Phase
      • Liquid Phase
      • Hybrid & Recombinant
      • By Application:
      • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
      • Diagnosis
      • Research
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
      • Academic and Research Institutes
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Product:
      • Reagents & Consumables
      • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
      • By Technology:
      • Solid Phase
      • Liquid Phase
      • Hybrid & Recombinant
      • By Application:
      • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
      • Diagnosis
      • Research
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
      • Academic and Research Institutes
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Product:
      • Reagents & Consumables
      • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
      • By Technology:
      • Solid Phase
      • Liquid Phase
      • Hybrid & Recombinant
      • By Application:
      • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
      • Diagnosis
      • Research
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
      • Academic and Research Institutes
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Product:
      • Reagents & Consumables
      • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
      • By Technology:
      • Solid Phase
      • Liquid Phase
      • Hybrid & Recombinant
      • By Application:
      • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
      • Diagnosis
      • Research
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
      • Academic and Research Institutes
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Product:
      • Reagents & Consumables
      • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
      • By Technology:
      • Solid Phase
      • Liquid Phase
      • Hybrid & Recombinant
      • By Application:
      • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
      • Diagnosis
      • Research
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
      • Academic and Research Institutes
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Product:
      • Reagents & Consumables
      • Equipment
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Equipment
      • By Technology:
      • Solid Phase
      • Liquid Phase
      • Hybrid & Recombinant
      • By Application:
      • Therapeutics
      • Metabolic Disorders
      • Cardiovascular Disorders
      • Respiratory Disorders
      • Infectious Diseases
      • Others
      • Diagnosis
      • Research
      • By End User:
      • Pharmaceutical and Biotechnology Companies
      • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
      • Academic and Research Institutes
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • GenScript Biotech Corporation.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Merck KGaA
    • ThermoFisher Scientific Inc.
    • Syngene
    • Lonza
    • Novo Nordisk A/S
    • Bachem Holding AG
    • Gyros Protein Technologies
    • Creative Diagnostics
    • CEM Corporation
    • PuroSynth
    • AAPPTec
    • Biotage AB

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Peptide Synthesis Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Peptide Synthesis Products

5. Global Peptide Synthesis Market, By Product, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Reagents & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Peptide Synthesizers
    • Lyophilizers
    • Chromatography Equipment

6. Global Peptide Synthesis Market, By Technology, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Solid Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Liquid Phase
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Hybrid & Recombinant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Peptide Synthesis Market, By Application, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Metabolic Disorders
    • Cardiovascular Disorders
    • Respiratory Disorders
    • Infectious Diseases
    • Others
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Peptide Synthesis Market, By End User, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

9. Global Peptide Synthesis Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Technology, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Application, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • GenScript Biotech Corporation.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • ThermoFisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Syngene
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lonza
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novo Nordisk A/S
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bachem Holding AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Gyros Protein Technologies
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Creative Diagnostics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CEM Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • PuroSynth
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AAPPTec
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biotage AB
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact